News
Novo Nordisk offers lower Ozempic price for customers whose insurance does not cover costs
People who are prescribed Ozempic to treat type 2 diabetes, but whose insurance does not cover it, or who don’t have insurance, will be able to buy the medication at a lower cost. Novo Nordisk announced on Monday that it will offer Ozempic for $499 a month through the GoodRx platform.
GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of ...
Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for $499, for those who pay for medications on their own and don’t go through ...
8hon MSN
Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
Who benefits? The reduced price applies to self-paying patients—those without insurance, or whose insurance doesn’t cover ...
Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 40.2% in the afternoon session after the company announced a ...
Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...
The maker of Ozempic is halving the price of its weight-loss jabs in the US after Donald Trump demanded cheaper drugs for ...
Patients who are prescribed Wegovy or Ozempic can now use GoodRx to access the medications at just $499 a month if they skip ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback